In recent years, multiple studies have illustrated that IL-10 is an effective anti-inflammatory cytokine, and increasing IL-10 production during ALI treatment can alleviate inflammation in injured lung tissues (33–35). The gene discussed is IL10; the disease is acute respiratory distress syndrome.